HESTER BIOSCIENCES LTD (HESTERBIO)

NSE: ₹1,922.40
BSE: ₹1,919.70
Stock Performance
Corporate Announcements
Announcement Under Regulation 30 Of Listing Regulations - Disclosure On Amendments In Loan Agreement Of Hester Africa

Announcement under Regulation 30 of Listing Regulation - Amendments in Loan agreement of Hester Africa

2026-05-20 16:01:00
Intimation Of Submission Of The Reclassification Application Under Regulation 31A Of Listing Regulations

Intimation of Submission of reclassification application with the stock exchanges under Regulations 31A of Listing Regulations

2026-05-20 10:52:36
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the year ended 31 March 2026

2026-05-18 09:58:46
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Transcript of Earnings Conference Call held on 15 May 2026

2026-05-18 09:45:07
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper clippings of Financial Results for Q4 & FY26 ended 31 March 2026

2026-05-18 09:37:05
Announcement Under Regulation 30 (LODR) - Corporate Presentation

Hester's Corporate Presentation for FY 2025-26

2026-05-15 17:03:24
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Audio recording of the Earnings Conference Call held on 15 May 2026

2026-05-15 16:27:29
Disclosure On Board Approval For Re-Classification Request Under Regulation 31A Of SEBI Listing Regulations

Disclosure on Board Approval for re-classification requests under Regulation 31A of SEBI Listing Regulations

2026-05-15 12:25:03
Intimation Of Receipt Of Requests For Reclassification From The “Promoters” To The “Public” Category In Accordance With Regulation 31A Of SEBI Listing Regulations

Intimation of receipt of requests for reclassification from Promoters to public category in accordance with SEBI listing Regulations

2026-05-15 12:22:12
Announcement under Regulation 30 (LODR)-Change in Management

Board considered and recommended the re-appointment of Ms. Priya Gandhi as Executive Director of the Company for the period of 3 years with effect from 28 October 2026, subject to approval of shareholders

2026-05-15 12:08:15

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 87.85 70.46 66.98 79.26 82.27 83.69 63.22 81.93 84.11 70.97 77.42 100.11
YOY Revenue Growth % 73.3% -3.69% -10.62% 17.77% -6.36% 18.79% -5.62% 3.37% 2.23% -15.2% 22.46% 22.2%
Other Income 1.15 4.36 0.99 4.15 1.23 1.84 7.81 -6.95 2.32 9.73 0.67 -3.03
Total Income 89.00 74.81 67.97 83.40 83.49 85.53 71.03 74.98 86.42 80.70 78.08 97.08
Total Expenses + 81.46 69.60 62.77 74.01 73.76 74.62 58.64 72.54 67.28 65.81 65.88 76.79
Cost of Materials Consumed 12.22 14.29 13.34 14.47 15.95 15.91 16.53 15.56 13.56 17.43 18.34 21.30
Employee Benefit Expense 16.00 16.45 15.58 16.10 16.00 15.90 16.34 14.19 15.28 15.50 15.52 16.37
Other Expenses 23.32 21.27 20.61 25.69 25.18 24.12 22.19 27.81 23.55 24.43 23.38 29.96
Operating Profit 6.40 0.86 4.21 5.24 8.51 9.07 4.58 9.39 16.82 5.16 11.54 23.32
OPM % 7.3% 1.2% 6.3% 6.6% 10.3% 10.8% 7.2% 11.5% 20% 7.3% 14.9% 23.3%
Profit Before Tax + 7.54 5.21 5.20 9.39 9.73 10.91 12.39 2.44 19.14 14.88 12.21 23.23
Tax Expense 0.83 1.17 1.18 2.99 2.25 2.52 0.98 0.89 1.84 0.55 2.90 6.69
Tax % 11% 22.5% 22.7% 31.9% 23.1% 23.1% 7.9% 36.7% 9.6% 3.7% 23.7% 28.8%
Profit After Tax 6.71 4.04 4.02 6.40 7.49 8.39 11.41 1.54 17.30 14.33 9.31 16.55
EPS (Basic) 7.89 4.75 4.73 7.52 8.80 9.86 13.41 1.82 20.33 16.85 10.94 19.45

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 332.60 311.10 304.55 266.09 235.01 214.33 183.27
YOY Revenue Growth % 6.91% 2.15% 14.45% 13.23% 9.65% 16.95% -
Other Income 9.68 3.92 10.64 15.15 13.74 4.68 6.37
Total Income 342.28 315.03 315.18 281.24 248.75 219.02 189.63
Total Expenses + 275.76 279.56 287.84 245.50 195.67 134.11 148.31
Cost of Materials Consumed 70.62 63.95 54.31 52.99 60.65 38.66 29.36
Employee Benefit Expense 62.67 62.42 64.13 56.02 45.33 38.92 40.65
Other Expenses 101.32 99.30 90.88 81.98 66.98 56.53 67.51
Operating Profit 56.84 31.55 16.71 20.59 39.34 80.22 34.96
OPM % 17.1% 10.1% 5.5% 7.7% 16.7% 37.4% 19.1%
Profit Before Exceptional 66.53 35.47 27.34 35.75 53.08 53.42 41.33
Exceptional Items 2.94 0.00 0.00 0.00 0.00 -3.32 0.00
Profit Before Tax + 69.46 35.47 27.34 35.75 53.08 50.10 41.33
Tax Expense 11.98 6.65 6.18 7.71 13.60 15.41 10.32
Tax % 17.2% 18.7% 22.6% 21.6% 25.6% 30.7% 25%
Profit After Tax 57.48 28.83 21.17 28.04 39.48 34.70 31.00
EPS (Basic) 67.57 33.89 24.88 32.96 46.41 40.79 36.44

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 469.38 458.21 447.73 442.37 367.40 0.00 226.86
Property, Plant & Equipment 411.06 232.68 239.47 258.90 236.81 0.00 136.86
Capital Work in Progress 0.00 176.67 168.11 146.14 80.22 0.00 74.15
Non-Current Investments 2.30 0.00 0.00 25.31 21.24 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.40 0.63 0.64 0.47 0.36 0.00 5.39
Current Assets + 208.56 195.17 214.62 227.59 194.76 0.00 157.62
Inventories 72.53 70.38 75.58 84.81 75.38 0.00 63.97
Trade Receivables 95.36 73.18 78.65 79.63 55.28 0.00 58.44
Cash and Cash Equivalents 2.77 5.59 12.75 13.16 24.75 0.00 23.09
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 367.79 326.66 302.88 288.55 267.39 0.00 206.49
Equity Share Capital 8.51 8.51 8.51 8.51 8.51 0.00 8.51
Other Equity 351.73 305.75 283.29 271.22 251.48 0.00 192.57
Non-Current Liabilities 157.67 201.55 253.69 232.72 197.87 0.00 96.64
Current Liabilities 152.48 125.18 105.79 148.70 96.90 0.00 81.34
Total Liabilities 310.15 326.73 359.47 381.42 294.77 0.00 177.98

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 64.14 64.51 48.13 23.60 8.81 0.00 0.00
Cash from Investing Activities -3.29 -19.00 -22.65 -77.00 -116.59 0.00 0.00
Cash from Financing Activities -48.79 -51.72 -26.05 41.76 111.61 0.00 0.00
Net Increase/Decrease in Cash -2.82 -6.72 -0.41 -11.59 3.48 0.00 0.00